Page last updated: 2024-09-03
imatinib mesylate and Liver Cirrhosis, Biliary
imatinib mesylate has been researched along with Liver Cirrhosis, Biliary in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Barbu, V; Francoz, C; Housset, C; Hultcrantz, R; Kinnman, N; Poupon, R; Rey, C; Wendum, D | 1 |
Other Studies
1 other study(ies) available for imatinib mesylate and Liver Cirrhosis, Biliary
Article | Year |
---|---|
The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis.
Topics: Actins; Animals; Benzamides; Bile Ducts; Cell Differentiation; Cell Lineage; Collagen; Desmin; Disease Models, Animal; Fibroblasts; Imatinib Mesylate; Kupffer Cells; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Phenotype; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |